Prihlásiť sa Zaregistrujte sa zadarmo

Rok IPO spoločnosti Alimera Sciences

Aká je hodnota metriky Rok IPO spoločnosti Alimera Sciences?

Hodnota metriky Rok IPO spoločnosti Alimera Sciences Inc. je 2010

Aká je definícia metriky Rok IPO?

IPO je rok počiatočnej verejnej ponuky akcií spoločnosti, kedy sa začnú akcie firmy verejne obchodovať.

Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.

Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.

The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.

Rok IPO spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Alimera Sciences

Čomu sa venuje spoločnosť Alimera Sciences?

alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.

Firmy s metrikou rok ipo podobnou spoločnosti Alimera Sciences